- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06893575
WhatsApp-Based Sleep Intervention in Heart Failure Patients (WhatSleeP-HF)
WhatSleeP-HF Trial: The Effect of a WhatsApp-Based Sleep Intervention on Sleep Quality in Heart Failure Patients, Based on the Transtheoretical Model: Two Center, Randomized Controlled Trial
Heart failure (HF) is a growing global health issue, with increasing prevalence among aging populations. In Turkey, the prevalence of HF was 2.114% in 2022, affecting approximately three million individuals. HF patients often experience poor sleep quality due to symptoms like dyspnea, fatigue, and fluid retention, which significantly impact their overall health and quality of life. Sleep disorders, particularly obstructive and central sleep apnea, are commonly reported among HF patients, exacerbating disease progression and increasing morbidity. Nurses play a crucial role in improving HF patients' self-care behaviors, including sleep hygiene interventions. Sleep hygiene consists of non-pharmacological strategies to improve sleep quality, such as maintaining a regular sleep schedule, avoiding electronic devices before bed, and minimizing caffeine and alcohol intake. However, behavior change in sleep hygiene requires structured intervention models, such as the Transtheoretical Model (TTM), which provides a stepwise approach to behavioral change, moving individuals through different stages from precontemplation to maintenance. TTM has been successfully applied in chronic disease management, including smoking cessation, diabetes self-care, hypertension control, and physical activity promotion. However, its application in HF patients, particularly for sleep interventions, remains underexplored. The limited existing studies suggest that HF patients often remain in the contemplation or preparation stages, indicating the need for tailored interventions to facilitate behavior change.
Advancements in digital health have enabled home-based sleep monitoring through wearable devices and mobile applications. Smartwatches, such as the Mi Band, provide real-time data on sleep parameters, offering a non-invasive alternative to traditional clinical sleep studies. Additionally, WhatsApp-based interventions have gained attention in healthcare, proving effective in chronic disease management by enhancing patient education, treatment adherence, and remote monitoring. WhatsApp facilitates real-time communication between patients and healthcare providers, reducing hospital readmissions and improving self-care practices. This study proposes a WhatsApp-based, TTM-guided sleep intervention for HF patients to improve sleep quality and self-care behaviors. Unlike previous studies, which primarily focus on general self-care education, this project integrates TTM with a digital platform to support sustained behavior change. Participants will receive personalized sleep hygiene guidance through WhatsApp, with regular reminders and real-time support. Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI) and Sleep Hygiene Index (SHI), alongside objective sleep parameters measured via smartwatches. The impact on quality of life (QoL) will be evaluated using the Minnesota Living with Heart Failure Questionnaire (MLHFQ).
Hypotheses H1. The WhatsApp-based, TTM-guided sleep health program will significantly improve subjective sleep quality in HF patients.
H2. The WhatsApp-based, TTM-guided sleep health program will significantly improve sleep hygiene in HF patients.
H3. The WhatsApp-based, TTM-guided sleep health program will significantly improve quality of life in HF patients.
This project is the first study to integrate TTM-based behavior change strategies with a WhatsApp sleep intervention for HF patients. The findings will provide novel insights into digital health interventions for chronic disease management and offer a scalable, cost-effective approach to improving sleep hygiene in HF populations.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
HF is a major global health concern, particularly in aging populations. In Turkey, HF prevalence reached approximately 2.114% in 2022, affecting nearly three million individuals. The condition leads to high hospitalization rates and significant healthcare costs. Given its increasing prevalence, improving self-care behaviors among HF patients is crucial. HF is a chronic disease that impairs the heart's ability to pump blood efficiently, leading to symptoms such as dyspnea, fatigue, and fluid retention. Beyond physical symptoms, HF patients frequently experience psychological issues like depression and anxiety, further compromising their QoL. Among the key determinants of reduced QoL in HF patients is poor sleep quality, which affects daily functioning and overall health status. Studies indicate that HF patients frequently suffer from sleep disturbances, including insomnia, obstructive sleep apnea (OSA), and central sleep apnea (CSA), all of which contribute to disease progression and increased morbidity risk. Addressing sleep quality in HF patients is an essential component of improving disease management and patient outcomes. Nurses, as key healthcare providers, play a pivotal role in implementing interventions to improve sleep hygiene, a critical yet often overlooked aspect of HF care. However, behavior change in sleep hygiene requires structured, evidence-based interventions that account for the complexities of adopting new habits.
Sleep hygiene refers to a set of non-pharmacological strategies designed to promote better sleep quality. These strategies include:
- Maintaining a consistent sleep schedule
- Reducing screen time before bed
- Minimizing caffeine, alcohol, and nicotine consumption
- Creating a comfortable sleep environment
- Engaging in physical activity during the day while avoiding excessive daytime naps
Despite these well-established guidelines, adherence to sleep hygiene recommendations remains a challenge, particularly among HF patients. Behavior change in chronic illness management is complex, requiring systematic approaches that help individuals transition from awareness to action and long-term maintenance. One effective approach for guiding behavior change is the TTM. TTM outlines five distinct stages of change:
- Precontemplation: No intention to change behavior
- Contemplation: Awareness of the need for change but no action taken
- Preparation: Intention to adopt change in the near future
- Action: Active engagement in behavior change
- Maintenance: Sustained behavior over time TTM has been successfully applied to a range of chronic disease interventions, including smoking cessation, diabetes self-management, and hypertension control. However, its use in HF patients-particularly for sleep hygiene interventions-remains limited. Previous studies suggest that most HF patients remain in the contemplation or preparation stages, indicating the need for targeted, stage-specific interventions that facilitate sustainable behavior change.
This study aims to develop and test a WhatsApp-based, TTM-guided sleep hygiene intervention for HF patients, evaluating its impact on sleep quality and overall quality of life. The intervention integrates TTM principles with a digital platform to promote sustainable sleep hygiene behaviors. Unlike previous HF interventions, which primarily focus on general self-care education, this project specifically targets sleep hygiene, using WhatsApp to provide continuous support, reminders, and feedback.
Hypotheses H1. The WhatsApp-based, TTM-guided sleep health program will significantly improve subjective sleep quality in HF patients.H2. The WhatsApp-based, TTM-guided sleep health program will significantly improve sleep hygiene in HF patients.
H3. The WhatsApp-based, TTM-guided sleep health program will significantly improve quality of life in HF patients.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bolu
-
Bolu, Bolu, Turkey (Türkiye), 14230
- Izzet Baysal Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Confirmed heart failure (HF) diagnosis for at least one year by a physician with echocardiographic verification.
- Echocardiographically confirmed left ventricular ejection fraction (LVEF) < 40%.
- Individuals with poor sleep quality and experiencing sleep problems (PSQI score ≥ 5).
- Not enrolled in any sleep improvement intervention program.
- Possessing a device capable of using WhatsApp (smartphone, tablet, computer, etc.) and having the necessary technical proficiency.
- Willingness to participate in the study
Exclusion Criteria:
- Presence of severe cognitive impairment (e.g., dementia, Alzheimer's disease) that may negatively affect the ability to use WhatsApp (Standardized Mini-Mental Test score < 25).
- Patients currently using sleep medications or sleep-regulating treatments. Individuals undergoing antidepressant or similar drug therapy.
- Patients with significant communication difficulties due to hearing or visual impairments or language barriers.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: TTM-Guided Digital Sleep Health Program
The experimental group will participate in a nurse-led intervention program titled "TTM-Guided Digital Sleep Health Program," designed to enhance sleep quality in HF patients. The intervention consists of:
Patients will track sleep data using smartwatches and share it via WhatsApp. The intervention follows the TTM, guiding patients through behavior change stages to improve and maintain sleep hygiene. |
This intervention is a TTM-based sleep health improvement program designed for HF patients.
It includes three components: (1) Sleep health education sessions (Weeks 1-4) delivered face-to-face and via telehealth, (2) WhatsApp-based sleep hygiene support (Weeks 5-12) with daily reminders, educational messages, and video content, and (3) Follow-up monitoring (Weeks 13-24) with periodic motivational messages.
Patients will track their sleep using smartwatches and share data via WhatsApp.
The intervention guides behavior change through TTM stages, promoting sustainable sleep hygiene practices.
|
|
No Intervention: Usual care group
The control group will not receive any intervention and will continue their routine treatment and follow-up in the outpatient clinic.
Surveys will be administered at designated data collection time points, and participants will be asked to keep a sleep diary for 14 days.
At the end of the intervention (at the end of the 6th month), written educational material will be provided to individuals in the control group.
This material will be created by compiling the sleep hygiene recommendations that were shared with the intervention group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep quality
Time Frame: from baseline to six months
|
PSQI is the most widely used scale in international literature to assess subjective sleep quality.
This scale was developed by Buysse et al. in 1989 and was adapted into Turkish with validity and reliability studies conducted by Ağargün et al.
The diagnostic sensitivity of the PSQI is 89.6%, and its specificity is 86.5%.
This self-report questionnaire allows for a detailed assessment of sleep quality, sleep disorders, and their severity over the past month.
The scale consists of 18 items grouped into seven components.
The maximum possible score is 21; scores above 5 indicate poor sleep quality, while scores below 5 indicate good sleep quality.
|
from baseline to six months
|
|
Sleep hygiene
Time Frame: from baseline to six months
|
SHI is a 13-item scale designed to assess whether and how frequently individuals engage in activities that affect sleep hygiene.
Each item is scored from 1 to 5, with a total score ranging from 13 to 65.
The scale evaluates sleep schedule regularity, pre-sleep behaviors that may negatively impact sleep hygiene (e.g., tobacco or caffeine consumption, engaging in demanding tasks, computer use), sleep environment conditions, and pre-sleep anxiety levels.
Higher scores indicate poorer sleep hygiene.
The scale does not have a validated cutoff score.
It was developed in 2006 and later adapted into Turkish with validity and reliability studies conducted in 2015.
|
from baseline to six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Sleep Quality
Time Frame: from baseline to six months
|
MLHFQ was developed in 1987 to assess quality of life in HF patients.
The scale consists of 21 items divided into two subdomains: physical functioning (8 items: 2,3,4,5,6,7,12,13) and emotional well-being (5 items: 17,18,19,20,21).
Items are rated on a Likert scale from 0 (no impact) to 5 (very much impact).
Subdomain scores are obtained by summing responses in each category, while the total score (0-105) reflects overall quality of life.
Physical function scores range from 0 to 40, and emotional scores from 0 to 105.
Lower scores indicate better quality of life (less dysfunction).
The scale was adapted into Turkish with validity and reliability studies conducted in 2009, showing Cronbach's alpha values above 0.70 for subdomains and total scores.
|
from baseline to six months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Şeyma Demir Erbaş, PhD, Abant Izzet Baysal University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AIBU-HSF-SDEMIR-06
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on TTM-Guided Digital Sleep Health Program
-
University of DelawareRecruitingPrediabetesUnited States
-
University Health Network, TorontoUnity Health Toronto; Women's College Hospital; MOUNT SINAI HOSPITALCompletedChronic Pain | Sleep | Sleep Disordered BreathingCanada
-
Pack HealthGlaxoSmithKline; University of WashingtonRecruitingMultiple Myeloma | Relapsed Hematologic MalignancyUnited States
-
University of TorontoCanadian Institutes of Health Research (CIHR)RecruitingCardiovascular Diseases | Dyslipidemia | Cardiovascular Risk Factors | Cholesterol | Major Cardiovascular EventCanada
-
Chang Hsiu-JuNational Science and Technology Council, TaiwanCompletedDepressive SymptomsTaiwan
-
National University of SingaporeNot yet recruitingAged | Cognition | Digital Health LiteracySingapore
-
Northwestern UniversityUniversity of Virginia; Tiny Blue Dot FoundationCompletedAnxietyUnited States
-
Johns Hopkins UniversityAmgen; NewAmsterdam PharmaRecruitingCardiovascular Risk | Implementation Science | Lipids | Digital Health | LDL-CUnited States
-
Pack HealthM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; The University... and other collaboratorsRecruitingBreast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Metastatic Cancer | Metastatic Breast Cancer | Endometrial Cancer | Head and Neck Cancers | Survivorship | Geriatric Oncology | Prostate CancersUnited States
-
Pack HealthM.D. Anderson Cancer Center; Sanofi; University of WashingtonRecruitingMultiple Myeloma | Refractory Multiple MyelomaUnited States